Welcome to our dedicated page for Surgery Partners SEC filings (Ticker: SGRY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Medicare rate updates, shifting payor mixes and physician joint-venture agreements turn every Surgery Partners disclosure into a maze of acronyms and footnotes. If you have ever searched through a 300-page document just to learn which facilities drove same-store growth, you know the challenge. Stock Titan brings clarity by pairing each release with AI-powered summaries that translate reimbursement tables and regulatory language into plain English.
You will find every filing here as soon as it hits EDGAR: the Surgery Partners annual report 10-K simplified for long-term trends, each Surgery Partners quarterly earnings report 10-Q filing broken down into case-volume and payor-mix drivers, and every Surgery Partners 8-K material events explained so you see why management moved quickly. Need trading intel? Our dashboard tracks Surgery Partners insider trading Form 4 transactions and delivers Surgery Partners Form 4 insider transactions real-time. For governance questions, the Surgery Partners proxy statement executive compensation section highlights how physician leaders are paid. All documents come with concise, AI-generated key points so you can start understanding Surgery Partners SEC documents with AI instead of parsing line items yourself.
Use these insights to compare segment margins across facilities, monitor Surgery Partners executive stock transactions Form 4 before earnings, and follow guidance revisions the moment they appear. Whether you are preparing a model, monitoring covenant compliance, or simply looking for Surgery Partners earnings report filing analysis, our platform saves hours and ensures nothing slips past you.
Schedule 13G/A (Amendment No. 2) – Surgery Partners, Inc. (SGRY)
Janus Henderson Group plc ("JHG") filed an amended Schedule 13G on 06/30/2025 reporting its beneficial ownership of Surgery Partners common stock. The filing, signed 07/07/2025, shows JHG and its investment-adviser subsidiaries collectively hold 12,954,916 shares, representing 10.1 % of the outstanding class. All voting and dispositive authority over these shares is reported as shared; JHG claims no sole power.
The Janus Henderson Contrarian Fund, a Massachusetts-organized investment vehicle within the JHG complex, is listed separately with 11,678,754 shares, or 9.1 % of the class, also entirely under shared voting and dispositive power.
- Reporting persons: Janus Henderson Group plc; Janus Henderson Contrarian Fund
- Total beneficial ownership (JHG): 12.95 million shares
- Ownership percentage: 10.1 %
- Event date: 06/30/2025
- Certification: Shares acquired & held in the ordinary course; no intent to influence control
Crossing the 10 % threshold makes JHG one of SGRY’s largest passive institutional shareholders and subjects it to ongoing reporting under Section 13(d). The filing contains no indication of activist intentions or transactions beyond the reported holdings.
FAQ
What is the current stock price of Surgery Partners (SGRY)?
What is the market cap of Surgery Partners (SGRY)?
What is the primary focus of Surgery Partners Inc?
How does Surgery Partners Inc differentiate itself in the healthcare market?
Which segments comprise the business model of Surgery Partners Inc?
What benefits does the integrated outpatient delivery model offer?
How does the company tailor its services to different local markets?
What types of ancillary services does Surgery Partners Inc offer?
How is the company positioned in the competitive landscape of healthcare services?
What key industry trends support the integrated model used by Surgery Partners Inc?
How does the integration of surgical and ancillary services impact patient care?
